LENSAR
LNSR | NASDAQ
$5.29
+$0.29 (+5.80%)
At close: Nov 16, 2026, 4:00 PM ET
$5.29
$0.00 (0.00%)
After-hours:
Nov 16, 2026, 7:30 PM ET
LENSAR Company Profile
Company profile explainedCompany Profile
LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser systems for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System, Europe, Asia, South Korea, and internationally. The company offers the LENSAR Laser System, which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment system that is designed to allow surgeons to perform sterile laser-assisted cataract surgery in a single operating room. LENSAR, Inc. was incorporated in 2004 and is headquartered in Orlando, Florida.
Key Executives
| Name | Position |
|---|---|
| Nicholas T. Curtis | President, Chief Executive Officer & Director |
| Alan Connaughton | Chief Operating Officer |
| Kendra W. Wong | Principal Accounting Officer |
| Michael A. Rossi | Interim CFO & Principal Financial Officer and Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 13, 2026 | 10-Q | Quarterly Report |
| Aug 13, 2026 | 8-K | Current Report |
| Aug 10, 2026 | 8-K | Current Report |
| Jul 29, 2026 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Jun 23, 2026 | DEFA14A | Filing |
| Jun 23, 2026 | ARS | Filing |
| Jun 23, 2026 | DEF 14A | Filing |
| Jun 05, 2026 | 4 | Filing |
| Jun 05, 2026 | 4 | Filing |
| Jun 05, 2026 | 4 | Filing |
LENSAR
| Country | United States |
| IPO Date | Oct 2, 2020 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 150 |
| CEO | Nicholas T. Curtis |
Contact Details
2800 Discovery Drive Orlando,
Florida 32826 United States
Stock Details
| Ticker Symbol | LNSR |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001320350 |
| CUSIP Number | 52634L108 |
| ISIN Number | US52634L1089 |
| SIC Code | 3841 |
Add to Watchlist
Select watchlists to add or remove LNSR